...
首页> 外文期刊>Molecular medicine reports >Upregulation of long noncoding RNA AP003419.16 predicts high risk of aging-associated idiopathic pulmonary fibrosis
【24h】

Upregulation of long noncoding RNA AP003419.16 predicts high risk of aging-associated idiopathic pulmonary fibrosis

机译:长度非划分RNA AP003419.16预测老化相关特发性肺纤维化的高风险

获取原文
获取原文并翻译 | 示例

摘要

Long noncoding RNAs (lncRNAs) are able to regulate adjacent genes and thus participate in the incidence in the present study has identified lncRNA AP003419.16, adjacent to the protein-coding gene ribosomal protein S6 kinase B-2 (RPS6KB2). RPS6KB2 is believed to be involved in the process of aging and idiopathic pulmonary fibrosis (IPF), due to its activation by growth factors and regulation by the protein kinase mTOR signaling pathway. The results of the present study indicated that the expression of AP003419.16 increased significantly in patients with IPF, whereas its adjacent gene ribosomal protein S6 kinase B-2 increased simultaneously. AP003419.16 expression may be used to predict an increased risk of aging-associated IPF. The present study provided a molecular hypothesis of IPF occurrence in the aging process, in addition to novel molecular targets for the clinical treatment of IPF.
机译:长度非编码RNA(LNCRNA)能够调节相邻基因,因此参与本研究的发病率已经鉴定了LNCRNA AP003419.16,邻近蛋白质编码基因核糖体蛋白S6激酶B-2(RPS6KB2)。 据信RPS6KB2涉及衰老和特发性肺纤维化(IPF)的过程,由于其通过蛋白激酶MTOR信号通路的生长因子和调节激活。 本研究的结果表明,IPF患者的AP003419.16的表达显着增加,而其相邻的基因核糖体蛋白S6激酶B-2同时增加。 AP003419.16表达可用于预测衰老相关的IPF的风险增加。 本研究提供了在衰老过程中的IPF发生的分子假设,除了用于临床治疗IPF的临床治疗的新分子靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号